Report on Reports: Cash Flow, Carbon, and the Bioeconomy

In this episode, Erum and Karl unpack six major reports that define the current state of synthetic biology and the bioeconomy. From investment trends to national security concerns, from manufacturing failures to trillion-dollar opportunities, these reports paint a complex picture of an industry at a critical turning point.


Chapters:


Previous
Previous

Crystal’s in the Cosmo’s: Varda Rewrites Drug Formulation in Microgravity

Next
Next

Live at BioFab Fair. Celebrating 150 Episodes!